# A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers

> **NCT01620931** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO5469754

## Key facts

- **NCT ID:** NCT01620931
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-07
- **Primary completion:** 2012-09-03
- **Final completion:** 2012-09-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620931, "A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01620931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*